-
Nimotuzumab on ASCO 2022
Oncoscience | June 7th, 2022
Once again, Nimotuzumab’s efficacy and safety in several cancer types were discussed and analyzed thorou...
-
Webinar – The Role of Nimotuzumab in the Treatment of Head and Neck and Nasopharyngeal Cancer
Oncoscience | May 28th, 2022
This webinar was conducted on May 28th, 2022 discussing the role of Nimotuzumab in the treatment of locall...
